Cyclosporine for the treatment of psoriasis
Brown, M.D.; Gupta, A.K.; Ellis, C.N.; Cooper, K.D.; Fisher, G.J.; Voorhees, J.J.
Transplantation Proceedings 20(3 Suppl 4: 26-31
1988
ISSN/ISBN: 0041-1345 PMID: 3381279 Document Number: 324764
Document emailed within 1 workday
Related Documents
Mrowietz, U.; Christophers, E. 1988: Effects of cyclosporine a treatment on psoriasis. I: Influence of low-dose cyclosporine on human monocyte function in vitro Transplantation Proceedings 20(3 Suppl 4: 53-57Wentzell, J.M.; Baughman, R.D.; O'Connor, G.T.; Bernier, G.M. 1987: Cyclosporine in the treatment of psoriasis Archives of Dermatology 123(2): 163-165
Zachariae, H.; Kragballe, K.; Hansen, H.E.; Marcussen, N.; Olsen, S. 1998: Renal biopsy in connection with long-term treatment of psoriasis with cyclosporine Ugeskrift for Laeger 160(31): 4534-4538
Silverman, A.K.; Emmett, M.; Menter, A. 1992: Can maintenance cyclosporine be used in psoriasis without decreasing renal function? Seminars in Dermatology 11(4): 302-312
Baker, B.S.; Griffiths, C.E.; Lambert, S.; Powles, A.V.; Leonard, J.N.; Valdimarsson, H.; Fry, L. 1988: The effects of cyclosporine a on T lymphocyte and dendritic cell subpopulations in psoriasis Transplantation Proceedings 20(3 Suppl 4: 72-77
Maskatia, Z.K.; Koo, J. 2007: Rebound of psoriasis after efalizumab discontinuation, despite being on high-dose cyclosporine Journal of Drugs in Dermatology: Jdd 6(9): 941-944
Lorber, M.I.; Flechner, S.M.; Van Buren, C.T.; Kerman, R.H.; Kahan, B.D. 1985: Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients Transplantation Proceedings 17(4 Suppl 1: 282-285
Ricotti, C.; Kerdel, F.A. 2007: Subacute annular generalized pustular psoriasis treated with etanercept and cyclosporine combination Journal of Drugs in Dermatology: Jdd 6(7): 738-740
Magliocco, M.A.; Lozano, A.M.; Van Saders, C.; Schuler, K.W.; Gottlieb, A.B. 2007: An open-label study to evaluate the transition of patients with chronic plaque psoriasis from cyclosporine to alefacept Journal of Drugs in Dermatology: Jdd 6(4): 424-427
Lain, E.L.; Markus, R.F. 2004: Early and explosive development of nodular basal cell carcinoma and multiple keratoacanthomas in psoriasis patients treated with cyclosporine Journal of Drugs in Dermatology: Jdd 3(6): 680-682
Chowaniec, O.; Blichowska, T. 1979: Case of generalized pustular psoriasis caused by corticosteroid treatment of simple psoriasis and pemphigus Przeglad Dermatologiczny 66(5): 541-544
Wong, J.W.; Kamangar, F.; Nguyen, T.V.; Koo, J.Y.M. 2012: Excimer laser therapy for hairline psoriasis: a useful addition to the scalp psoriasis treatment algorithm Skin Therapy Letter 17(5): 6-9
Au, S-Chung.; Madani, A.; Alhaddad, M.; Alkofide, M.; Gottlieb, A.B. 2013: Comparison of the efficacy of biologics versus conventional systemic therapies in the treatment of psoriasis at a comprehensive psoriasis care center Journal of drugs in dermatology: JDD 12(8): 861-866
Balevi, A.; Olmuşçelik, O.; Ustuner, P.; Özdemir, M. 2018: Is there any Correlation between Red Cell Distribution Width, Mean Platelet Volume Neutrophil Count, Lymphocyte Count, and Psoriasis Area Severity Index in Patients Under Treatment for Psoriasis? Acta Dermatovenerologica Croatica: Adc 26(3): 199-205
Ellis, C.N.; Fradin, M.S.; Hamilton, T.A.; Voorhees, J.J. 1995: Duration of remission during maintenance cyclosporine therapy for psoriasis. Relationship to maintenance dose and degree of improvement during initial therapy Archives of Dermatology 131(7): 791-795
Morozumi, K.; Thiel, G.; Albert, F.W.; Banfi, G.; Gudat, F.; Mihatsch, M.J. 1992: Studies on morphological outcome of cyclosporine-associated arteriolopathy after discontinuation of cyclosporine in renal allografts Clinical Nephrology 38(1): 1-8
Dieperink, H.; Kemp, E.; Leyssac, P.P.; Starklint, H.; Wanscher, M.; Nielsen, J.; Jørgensen, K.A.; Faber, V.; Flachs, H. 1986: Ketoconazole and cyclosporine A: combined effects on rat renal function and on serum and tissue cyclosporine a concentration Clinical Nephrology 25(Suppl 1): S137-S143
Anderson, J.E.; Morris, R.E.; Blaschke, T.F. 1987: Pharmacodynamics of cyclosporine-ketoconazole interaction in mice. Combined therapy potentiates cyclosporine immunosuppression and toxicity Transplantation 43(4): 529-533
Diliz, H.S.; Olivera, M.A.; Kershenobich, D.; Mercado, M.A.; Orozco, H. 1996: Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients Transplantation Proceedings 28(6): 3348-3350
Jacobs, T.W.; Katz, I.A.; Joffe, I.I.; Stein, B.; Takizawa, M.; Epstein, S. 1991: The effect of FK 506, cyclosporine A, and cyclosporine G on serum 1,25-dihydroxyvitamin D levels Transplantation Proceedings 23(6): 3188-3189